Keenova Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin 15
SEC filing record 1 source field available
Fiscal year end
31 December
Keenova Therapeutics plc has filed 1,415 SEC EDGAR filings since 01 Feb 2013

SEC filing history

Showing 101-125 of 1,000 matching filings.

Per page
25
Current page
5
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Aug 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87833

SCHEDULE 13D/A filing

Filing date
04 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .